The use of long-term opioid agonist and partial agonist medication is often reserved for older opioid-dependent individuals, while a brief detoxification with medication or medication-free treatment is offered to younger individuals. In a randomized trial, researchers evaluated the efficacy of buprenorphine-naloxone tapers of 2 versus 12 weeks in younger subjects. (Source: Alcohol, Tobacco and Other Drugs News)
The use of long-term opioid agonist and partial agonist medication is often reserved for older opioid-dependent individuals, while a brief detoxification with medication or medication-free treatment is offered to younger individuals. In a randomized trial, researchers evaluated the efficacy of buprenorphine-naloxone tapers of 2 versus 12 weeks in younger subjects. (Source: Alcohol, Tobacco and Other Drugs News)MedWorm Sponsor Message: Watch the new MedWorm demo and find out how to get all the very latest, relevant, organized information daily!